DISCLOSURES
Danny Vleggaar MD has been a medical consultant for Sinclair
IS Pharma, France; PharmaSwiss SA, Switzerland;
Valeant Eastern Europe; and Cutanea Life Sciences, Inc. He
also has been a trainer for Valeant Pharmaceuticals International,
Inc./Medicis Corporation.
Rebecca Fitzgerald MD has been a consultant and speaker for
Valeant Pharmaceuticals North America LLC/Medicis Corporation;
Merz Aesthetic, Inc; and Allergan USA, Inc.
Z. Paul Lorenc MD FACS has been a consultant for Johnson
& Johnson; La Lumiere, LLC; Medicis Corporation; Merz Corporation;
and Mentor Corporation. In addition, he holds the
following patents: US Patent 5/611,814–Resorbable Surgical
Appliance for Use in Supporting Soft Tissue in a Superior Position;
US Patent 60/950,423–Composition and Method of Use for
SoftTissue Augmentation/Drug Delivery; US Patent 12/797,710–
Method for Measuring Change in Lip Size After Augmentation;
and US Patent 13/604,012–Light Therapy Platform System.